Journals / Journal of Mood Disorders / 2016 / Cilt: 6 - Sayı: 1

Acneiform eruption developing with duloxetine: a case

Duloksetinle gelişen akneiform erupsiyon: Bir vaka

Pages
25–27
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, we report a female patient who developed acneiform eruption due to duloxetine use, a different side effect than usual side effects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Duloxetine, serotonin and norepinephrine reuptake inhibitor is a strong antidepressant.
📊
Key Findings & Data:It is widely used for generalized anxiety disorder, neuropathic pain and fibromyalgia syndrome as well as major depressive disorder.
💡
Conclusion & Impact:In this paper, we report a female patient who developed acneiform eruption due to duloxetine use, a different side effect than usual side effects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Duloxetine, serotonin and norepinephrine reuptake inhibitor is a strong antidepressant. It is widely used for generalized anxiety disorder, neuropathic pain and fibromyalgia syndrome as well as major depressive disorder. Its most important side effects are nausea, dryness of the mouth, constipation, sleep disorder, dizziness and fatigue. In this paper, we report a female patient who developed acneiform eruption due to duloxetine use, a different side effect than usual side effects.

Özet

Duloksetin serotonin ve norepinefrin gerialım inhibitörü olan güçlü bir antidepresandır. Majör depresif bozukluğun yanı sıra yaygın anksiyete bozukluğu, nöropatik ağrı ve fibromiyalji sendromunda da yaygın olarak kullanılmaktadır. En önemli yan etkileri bulantı, ağız kuruluğu, kabızlık, uyku bozukluğu, baş dönmesi ve yorgunluktur. Yazımızda bu yan etkilerden farklı olarak duloksetin kullanımıyla akneiform erüpsiyon gelişen bir kadın hastadan bahsedilmesi amaçlanmıştır.

🔖

Cite This Article

DEMİR, B., KORKMAZ, S., ATMACA, M., TEMİZKAN, A. (2022). Acneiform eruption developing with duloxetine: a case. Journal of Mood Disorders, Cilt: 6 - Sayı: 1, 25–27. https://ajindex.com/articles/564543

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Plewig G, Jansen T. Acneiform dermatoses. Dermatology. 1998;196:102-7.
  2. Walon L, Gilbeau C, Lachapelle JM. Acneiform eruptions induced by cetuximab. Ann Dermatol Venereol. 2003;130:443-6.
  3. Hu JC, Sadeghi P, Pinter-Brown LC, Yashar S, Chiu MW. Cutaneous side effects of epidermal growth factor receptor inhibitors: Clinical presentation, pathogenesis, and management. J Am Acad Dermatol. 2007;56:317-26.
  4. Trivedi MH, Desaiah D, Ossana MJ, Pritchett YL, Brannan SK, Detke MJ. Clinical evidence for serotonin and norepinefrine reuptake inhibition of duloxetine. Int Clin Psychopharmacol. 2008;23:161-9.
  5. Papakostas GI, Worthington JJ 3rd, Iosifescu DV, Kinrys G, Burns AM, Fisher LB, et al. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder. Depress Anxiety. 2006;23:178-81.
  6. A. Temizkan, S. Korkmaz, B. Demir, M. Atmaca Çorapçıoğlu A, Aydemir Ö, Yıldız M ve ark. (1999) DSM-IV Eksen I Bozuklukları (SCID-I) için Yapılandırılmış Klinik Görüşme, Klinik Versiyon. Ankara:
  7. Hekimler Yayın Birliği. Khanna S, Chirinos RE, Venna S. Escitalopram oxalate (Lexapro)- induced acneiform eruption. J Am Acad Dermatol. 2012;67:261-3.
  8. Sinha S, Udupa S, Bhandary RP, Praharaj SK, Munoli RN. Sertraline-Induced Acneiform Eruption. J Neuropsychiatry Clin Neurosci. 2014;26:56-7.
  9. Cederberg J, Knight S, Svenson S, Melhus H. Itch and skin rash from chocolate during fluoxetine and sertraline treatment: case report. BMC Psychiatry. 2004;4:36. Gould GG, Javors MA, Frazer A. Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain. Biol Psychiatry. 2007;61:210-5.
  10. Schalock PC, Zug KA. Acneiform reaction to erlotinib. Dermatitis. 2007;18:230-1.